| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243662 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 4 Pages |
Abstract
Conclusion: Targeted intraoperative radiotherapy combined with EBRT results in a low local recurrence rate. This could be attributed to both accurate targeting and timeliness of the treatment. These data support the need for a randomized trial to test whether the TARGIT boost is superior to conventional external boost, especially in high-risk women.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jayant S. M.B.B.S., M.S., D.N.B., F.R.C.S., Ph.D., F.R.C.S. (GEN), Michael M.B., F.R.C.S., C.H.M., M.D.(HON), F.R.C.R.(HON), Jeffrey S. M.D., F.R.C.R., Samuele M.D., Frederik M.D., Olive B.Sc., Basil M.D., Joan B.Sc., Christobel M.D., F.R.C.S.,